```html

Koenig’s Disease (Tarsal Coalition)

Overview

Koenig’s disease, more commonly referred to as tarsal coalition, is a congenital (present at birth) condition in which two or more of the small bones in the rear foot—known as the tarsal bones—are abnormally joined together by bone, cartilage, or fibrous tissue. The most frequent coalitions involve the calcaneonavicular (calcaneus‑navicular) or talocalcaneal (talus‑calcaneus) joints.

Because the coalition limits normal motion of the subtalar joint, patients may develop pain, stiffness, and a flatfoot (pes planus) deformity. The condition is named after the German surgeon **Rudolf Koenig**, who first described it in the early 20th century.

Who It Affects

• Typically presents during late childhood to early adulthood (12‑25 years) when the coalition begins to ossify.
• Both sexes are affected equally, though some series report a slight male predominance (≈55 %).
• Most cases are isolated (single coalition), but 10‑15 % have multiple coalitions or are associated with other congenital foot anomalies.

Prevalence

Estimates vary because many people remain asymptomatic, but epidemiologic studies suggest:

• Overall prevalence in the general population: 1–2 % (≈1 in 100 individuals).
• Symptomatic tarsal coalition requiring medical attention: 0.2–0.5 % (≈1 in 250–500).
• Higher prevalence in families with a history of foot malformations, indicating a hereditary component (autosomal dominant pattern with variable penetrance).<sup>[1]</sup>

Symptoms

Symptoms may be absent for years. When they appear, they often mimic other foot problems, which can delay diagnosis. Common manifestations include:

• Mid‑foot or hind‑foot pain – achy, deep‑seated pain that worsens with activity, especially running, jumping, or prolonged standing.
• Stiffness – limited inversion (turning the sole inward) and eversion (turning outward), making it difficult to walk on uneven surfaces.
• Flatfoot (pes planus) – collapse of the arch due to restricted subtalar motion.
• Locomotor changes – a “toe‑walking” gait, limping, or "out-toeing" stance.
• Swelling or tenderness over the coalition site, most often over the sinus tarsi (the space between the talus and calcaneus).
• Recurrent sprains – instability of the ankle because the subtalar joint cannot absorb forces normally.
• Night pain or pain that awakens the patient, especially when the coalition becomes partially ossified.
• Decreased athletic performance – athletes may notice a loss of speed or endurance, particularly in sports that involve running or jumping.

Causes and Risk Factors

Underlying Mechanism

Tarsal coalition results from a failure of the normal segmentation of the embryonic foot. During fetal development, the cartilaginous precursors of the tarsal bones should separate (apoptosis of intervening cells). In Koenig’s disease, this separation is incomplete, leaving a bridge of tissue.

Genetic Factors

• Most cases are sporadic, but up to 30 % have a familial pattern.
• Mutations in the HOXA13 and HOXD13 genes have been linked to tarsal coalition in rare families.<sup>[2]</sup>

Associated Conditions

• Accessory navicular bone – an extra bone on the inner side of the foot.
• Peroneal spastic flatfoot (also called “tarsal coalition syndrome”).
• Other congenital foot anomalies such as talocalcaneal osteochondral lesions.

Risk Factors

• Family history of foot deformities.
• Participation in high‑impact sports during adolescence (which may accelerate ossification of the coalition).
• Obesity – increased load can aggravate pain earlier.
• Previous ankle sprains – may unmask latent stiffness.

Diagnosis

A thorough clinical assessment is essential, followed by targeted imaging.

History & Physical Examination

• Onset, location, and character of pain.
• Functional limitations (running, climbing stairs, etc.).
• Family history of foot problems.
• Inspection for flatfoot, valgus hindfoot, or forefoot abduction.
• Palpation of the sinus tarsi and calcaneonavicular region.
• Range‑of‑motion testing of inversion/eversion.

Imaging Studies

1. Plain Radiography – weight‑bearing lateral and AP views can show the classic “tarsal coalitions”:
   • Calcaneonavicular coalition appears as a "C‑sign" on lateral view.
   • Talocalcaneal coalition may produce a “tarsal sandal” sign.
2. Computed Tomography (CT) – provides detailed bone anatomy, identifies the exact size and orientation of the coalition, and helps surgical planning.<sup>[3]</sup>
3. Magnetic Resonance Imaging (MRI) – best for visualizing fibrocartilaginous or cartilaginous coalitions and associated soft‑tissue inflammation.
4. Bone Scintigraphy – occasionally used to differentiate painful from asymptomatic coalitions (increased uptake indicates active inflammation).

Diagnostic Criteria

A diagnosis is made when clinical symptoms (pain, limited motion, flatfoot) correlate with radiographic evidence of a tarsal bridge.

Treatment Options

Management is individualized based on severity, activity level, and patient goals.

Conservative (Non‑Surgical) Care

• Activity Modification – reduce high‑impact activities (running, basketball) and replace with low‑impact options (swimming, cycling).
• Physical Therapy – focus on:
  • Stretching of the gastrocnemius‑soleus complex to improve ankle dorsiflexion.
  • Strengthening intrinsic foot muscles and peroneals to enhance stability.
  • Proprioceptive and balance exercises.
• Orthotic Devices:
  • Custom arch‑supporting insoles or medial heel wedges to off‑load the coalition.
  • Full‑length rigid or semi‑rigid foot orthoses for severe flatfoot.
• Medications:
  • Non‑steroidal anti‑inflammatory drugs (NSAIDs) such as ibuprofen 400‑600 mg q6‑8 h for pain control (use per label).
  • Acetaminophen or topical NSAIDs for patients who cannot tolerate oral agents.
• Corticosteroid Injection – ultrasound‑guided injection into the sinus tarsi can provide temporary relief (usually 3‑6 months). Repeat injections are limited due to cartilage risk.
• Weight Management – a 5‑10 % reduction in body weight can lessen mechanical stress on the subtalar joint.

Surgical Intervention

Surgery is considered when conservative measures fail after 3–6 months, or when the coalition severely limits function.

1. Coalition Resection (Excision) – removal of the bony/cartilaginous bridge, often combined with interpositional graft (e.g., fat or fascia) to prevent re‑fusion.
2. Arthrodesis (Fusion) – in cases with extensive arthritis or chronic pain, surgeons may fuse the subtalar joint to eliminate motion and pain.
3. Adjunct Procedures:
   • Calcaneal osteotomy to correct hindfoot valgus.
   • Soft‑tissue releases for peroneal spastic flatfoot.

Post‑operative protocol typically includes immobilization in a walking boot for 4‑6 weeks, followed by graduated weight‑bearing and physical therapy. Success rates for coalition resection range from 80‑90 % with significant pain reduction.<sup>[4]</sup>

Emerging & Adjunct Therapies

• Platelet‑rich plasma (PRP) injections – limited evidence, potentially helpful for adjunctive pain control.
• Shock‑wave therapy – pilot studies suggest modest short‑term pain reduction.
• 3‑D printed custom orthoses – improved fit and load distribution, currently under research.

Living with Koenig’s Disease (Tarsal Coalition)

Even after successful treatment, many individuals need ongoing strategies to keep the foot healthy.

Daily Management Tips

• Wear supportive shoes with a firm heel counter and adequate arch support; avoid high‑heels or shoes with a soft, flexible sole.
• Use orthotics as prescribed; replace them every 12‑18 months or sooner if they wear out.
• Warm‑up and stretch before activity—calf stretches, ankle circles, and toe‑grip exercises reduce strain.
• Strengthen daily – a 10‑minute foot‑strengthening routine (e.g., towel scrunches, marble pick‑ups) can improve intrinsic muscle tone.
• Monitor pain – keep a log of activity, pain level (0‑10 scale), and any swelling to discuss with your provider.
• Maintain a healthy weight – aim for a BMI < 25 kg/m² if possible.
• Cross‑train – incorporate low‑impact cardio (swimming, elliptical) to keep cardiovascular fitness without overloading the foot.
• Regular follow‑up – at least annually with a podiatrist or orthopedic foot specialist, or sooner if symptoms change.

Work and Sports Considerations

• For occupations requiring prolonged standing, use cushioned anti‑fatigue mats and shoe inserts.
• In sports, consider playing on softer surfaces and limit repetitive jumping.
• Discuss a “return‑to‑play” plan with a sports medicine physician after surgery—most athletes resume activity 3–4 months post‑resection.

Prevention

Because the primary cause is congenital, complete prevention is not possible. However, symptomatic disease can often be delayed or mitigated:

• Early detection – family members of a known case should be screened with a standing foot X‑ray in late childhood.
• Maintain good foot biomechanics – proper footwear during growth years helps the developing arch.
• Gradual activity increase – avoid sudden spikes in intensity that could stress an unossified coalition.
• Weight control – healthy nutrition and regular exercise during childhood reduce downstream stress on the subtalar joint.

Complications

If left untreated, tarsal coalition can lead to several downstream problems:

• Chronic Subtalar Arthritis – abnormal joint mechanics cause wear and tear.
• Progressive Flatfoot Deformity – may become rigid and painful.
• Recurrent Ankle Instability – increasing risk of sprains and possible ligament injury.
• Degenerative Changes in Adjacent Joints – such as the talonavicular or calcaneocuboid joints.
• Reduced Athletic Participation – persistent pain can limit sports involvement and affect quality of life.

When to Seek Emergency Care

Key References

1. Mendoza-Lattes et al., “Genetic aspects of tarsal coalition,” *Journal of Orthopaedic Research*, 2016.
2. Levine et al., “HOXA13 and HOXD13 mutations in familial tarsal coalition,” *Human Genetics*, 2017.
3. Cleveland Clinic – Tarsal Coalition Overview.
4. Mayo Clinic – Diagnosis and Treatment of Tarsal Coalition.
5. American College of Foot and Ankle Surgeons. *Clinical Guidelines for the Management of Tarsal Coalition* (2022).
6. World Health Organization. *International Classification of Diseases (ICD‑10)* – Code Q68.3 for tarsal coalition.

```